Celldex Therapeutics reported $2.61B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 444.6B 59.91B Jun/2026
Agenus USD 128M 21M Mar/2026
Amgen USD 195.44B 5.55B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Celldex Therapeutics USD 2.92B 809M Jun/2026
Glaxosmithkline GBP 109.29B 9.36B Mar/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Northwest Biotherapeutics USD 332M 24M Mar/2026
Pfizer USD 138.44B 15.37B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026